Trypanotliione reductase and lipoamide dehydrogenase as targets for a structure‐based drug design
Autor: | R Schöneck, R L Krauth-Siegel |
---|---|
Rok vydání: | 1995 |
Předmět: | |
Zdroj: | The FASEB Journal. 9:1138-1146 |
ISSN: | 1530-6860 0892-6638 |
Popis: | Trypanothione reductase (TR) is a flavoenzyme that has been found only in parasitic protozoa of the order Kinetoplastida. The enzyme catalyzes the NADPH-dependent reduction of glutathionylspermidine conjugates and is a key enzyme of the parasite's thiol metabolism. Consequently, TR is an attractive target molecule for a structure-based drug development against Chagas' disease, African sleeping sickness, and other diseases caused by trypanosomes and leishmanias. The three-dimensional structures of TR and of three enzyme substrate complexes have been solved. Several classes of compounds are discussed as guide structures for the design of specific inhibitors. Among them are tricyclic compounds such as acridines and phenothiazines, which competitively inhibit TR but not the related host enzyme glutathione reductase, as well as oxidase activity-inducing quinones and nitrofurans. Lipoamide dehydrogenase (LipDH) is another flavoprotein discussed as a target molecule for an antitrypanosomal therapy. In Trypanosom... |
Databáze: | OpenAIRE |
Externí odkaz: |